ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 736829 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 736829; 2) Community: the network communities that were significantly associated with the response to NSC 736829; 3) Molecule: the relationships between components within communities and NSC 736829; 4) MDR: the compounds that were significantly associated with the NSC 736829.

NSC Compound Enrichment Correlation
NSC 737344 6-(3-Aminopropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline Hydrochloride 0.0273093708703111 0.77033497
NSC 743265 Null 0.0273093708703111 -0.069310518
NSC 747652 2,3-DIMETHOXY-1-NITROSOPYRIDO[3',2':4,5]PYRROLO[1,2-C][1,2,3]BENZOTRIAZINE 0.0273093708703111 0.62555527
NSC 762583 Null 0.0273093708703111 -0.35266094
NSC 100046 Elephantopin 0.0273093708703114 0.1526781
NSC 113951 6-Bromotoyocamycin 0.0273093708703114 0.53548911
NSC 129943 (+-)-(3,5,3',5'-Tetraoxo)-1,2-dipiperazinopropane 0.0273093708703114 0.57493477
NSC 251805 Butanedioic acid, 2-bromo-3-fluoro-, dimethyl ester 0.0273093708703114 0.40249422
NSC 327182 L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]benzoyl]- 0.0273093708703114 0.21691783
NSC 58239 A 80021F34 0.0273093708703114 0.48923371
Total:73  Current:49    [First] [Prev] [Next] [Last]